Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.000
-0.070 (-6.54%)
At close: Feb 21, 2025, 4:00 PM
1.050
+0.050 (5.00%)
After-hours: Feb 21, 2025, 4:14 PM EST
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of $40.23 million as of February 21, 2025. Its market cap has decreased by -59.41% in one year.
Market Cap
40.23M
Enterprise Value
-53.20M
1-Year Change
-59.41%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since the IPO on April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from $579.09M to $40.23M, a decrease of -93.05%. That is a compound annual growth rate of -50.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 40.23M | -17.22% |
| Dec 31, 2024 | 48.60M | -65.85% |
| Dec 29, 2023 | 142.31M | 62.36% |
| Dec 30, 2022 | 87.65M | -77.38% |
| Dec 31, 2021 | 387.51M | -33.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |